These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 27863231)

  • 21. Comparison of the phenotypes of patients harboring in-frame deletions starting at exon 45 in the Duchenne muscular dystrophy gene indicates potential for the development of exon skipping therapy.
    Nakamura A; Shiba N; Miyazaki D; Nishizawa H; Inaba Y; Fueki N; Maruyama R; Echigoya Y; Yokota T
    J Hum Genet; 2017 Apr; 62(4):459-463. PubMed ID: 27974813
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Moving towards successful exon-skipping therapy for Duchenne muscular dystrophy.
    Nakamura A
    J Hum Genet; 2017 Oct; 62(10):871-876. PubMed ID: 28566768
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gene therapy for muscle disease.
    Miyagoe-Suzuki Y; Takeda S
    Exp Cell Res; 2010 Nov; 316(18):3087-92. PubMed ID: 20580709
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intravenous infusion of an antisense oligonucleotide results in exon skipping in muscle dystrophin mRNA of Duchenne muscular dystrophy.
    Takeshima Y; Yagi M; Wada H; Ishibashi K; Nishiyama A; Kakumoto M; Sakaeda T; Saura R; Okumura K; Matsuo M
    Pediatr Res; 2006 May; 59(5):690-4. PubMed ID: 16627883
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New developments in the use of gene therapy to treat Duchenne muscular dystrophy.
    Jarmin S; Kymalainen H; Popplewell L; Dickson G
    Expert Opin Biol Ther; 2014 Feb; 14(2):209-30. PubMed ID: 24308293
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Optimizing antisense oligonucleotides using phosphorodiamidate morpholino oligomers.
    Popplewell LJ; Malerba A; Dickson G
    Methods Mol Biol; 2012; 867():143-67. PubMed ID: 22454060
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Becker muscular dystrophy patients with deletions around exon 51; a promising outlook for exon skipping therapy in Duchenne patients.
    Helderman-van den Enden AT; Straathof CS; Aartsma-Rus A; den Dunnen JT; Verbist BM; Bakker E; Verschuuren JJ; Ginjaar HB
    Neuromuscul Disord; 2010 Apr; 20(4):251-4. PubMed ID: 20153965
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of mutation profiles in the Duchenne muscular dystrophy gene among populations: implications for potential molecular therapies.
    López-Hernández LB; Gómez-Díaz B; Luna-Angulo AB; Anaya-Segura M; Bunyan DJ; Zúñiga-Guzman C; Escobar-Cedillo RE; Roque-Ramírez B; Ruano-Calderón LA; Rangel-Villalobos H; López-Hernández JA; Estrada-Mena FJ; García S; Coral-Vázquez RM
    Int J Mol Sci; 2015 Mar; 16(3):5334-46. PubMed ID: 25761239
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exon-skipping advances for Duchenne muscular dystrophy.
    Echevarría L; Aupy P; Goyenvalle A
    Hum Mol Genet; 2018 Aug; 27(R2):R163-R172. PubMed ID: 29771317
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rescue of dystrophin mRNA of Duchenne muscular dystrophy by inducing exon skipping.
    Matsuo M; Takeshima Y
    Acta Myol; 2005 Oct; 24(2):110-4. PubMed ID: 16550927
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Precise correction of the dystrophin gene in duchenne muscular dystrophy patient induced pluripotent stem cells by TALEN and CRISPR-Cas9.
    Li HL; Fujimoto N; Sasakawa N; Shirai S; Ohkame T; Sakuma T; Tanaka M; Amano N; Watanabe A; Sakurai H; Yamamoto T; Yamanaka S; Hotta A
    Stem Cell Reports; 2015 Jan; 4(1):143-154. PubMed ID: 25434822
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Duchenne and Becker muscular dystrophy: from gene diagnosis to molecular therapy.
    Matsuo M
    IUBMB Life; 2002 Mar; 53(3):147-52. PubMed ID: 12102170
    [TBL] [Abstract][Full Text] [Related]  

  • 33. From gRNA Identification to the Restoration of Dystrophin Expression: A Dystrophin Gene Correction Strategy for Duchenne Muscular Dystrophy Mutations Using the CRISPR-Induced Deletion Method.
    Duchêne B; Iyombe-Engembe JP; Rousseau J; Tremblay JP; Ouellet DL
    Methods Mol Biol; 2018; 1687():267-283. PubMed ID: 29067670
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical phenotypes as predictors of the outcome of skipping around DMD exon 45.
    Findlay AR; Wein N; Kaminoh Y; Taylor LE; Dunn DM; Mendell JR; King WM; Pestronk A; Florence JM; Mathews KD; Finkel RS; Swoboda KJ; Howard MT; Day JW; McDonald C; Nicolas A; Le Rumeur E; Weiss RB; Flanigan KM;
    Ann Neurol; 2015 Apr; 77(4):668-74. PubMed ID: 25612243
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Less is more: therapeutic exon skipping for Duchenne muscular dystrophy.
    Aartsma-Rus A; van Ommen GJ
    Lancet Neurol; 2009 Oct; 8(10):873-5. PubMed ID: 19713153
    [No Abstract]   [Full Text] [Related]  

  • 36. [Effective exon skipping in humans: a symbolic but promising jump into DMD therapy].
    Kaplan JC; Chelly J; Garcia L
    Med Sci (Paris); 2008 Feb; 24(2):215-7. PubMed ID: 18272087
    [No Abstract]   [Full Text] [Related]  

  • 37. Exon skipping therapy for Duchenne muscular dystrophy.
    Kole R; Krieg AM
    Adv Drug Deliv Rev; 2015 Jun; 87():104-7. PubMed ID: 25980936
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Deletion of Dystrophin In-Frame Exon 5 Leads to a Severe Phenotype: Guidance for Exon Skipping Strategies.
    Toh ZY; Thandar Aung-Htut M; Pinniger G; Adams AM; Krishnaswarmy S; Wong BL; Fletcher S; Wilton SD
    PLoS One; 2016; 11(1):e0145620. PubMed ID: 26745801
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Eteplirsen in the treatment of Duchenne muscular dystrophy.
    Lim KR; Maruyama R; Yokota T
    Drug Des Devel Ther; 2017; 11():533-545. PubMed ID: 28280301
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antisense oligonucleotide-induced exon skipping restores dystrophin expression in vitro in a canine model of DMD.
    McClorey G; Moulton HM; Iversen PL; Fletcher S; Wilton SD
    Gene Ther; 2006 Oct; 13(19):1373-81. PubMed ID: 16724091
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.